Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes Mellitus

NCT01364428 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

373

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: insulin degludec
DRUG: insulin degludec

Sponsor

Novo Nordisk A/S